US Stock MarketDetailed Quotes

Neurocrine Biosciences (NBIX)

Watchlist
  • 158.420
  • -0.630-0.40%
Close May 15 16:00 ET
  • 158.420
  • 0.0000.00%
Post 20:01 ET
15.93BMarket Cap24.37P/E (TTM)

Neurocrine Biosciences (NBIX) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
125.00%145.8M
31.46%782.7M
60.16%388.4M
43.99%227.5M
57.89%102M
-50.27%64.8M
52.71%595.4M
96.36%242.5M
-25.47%158M
-64.03%64.6M
Net income from continuing operations
2,405.06%197.9M
40.23%478.6M
49.08%153.7M
61.40%209.5M
65.38%107.5M
-81.80%7.9M
36.68%341.3M
-30.20%103.1M
56.20%129.8M
-31.94%65M
Operating gains losses
---28.6M
----
----
----
----
----
----
----
----
----
Depreciation and amortization
-3.95%7.3M
11.07%30.1M
5.63%7.5M
18.46%7.7M
0.00%7.3M
22.58%7.6M
27.23%27.1M
24.56%7.1M
18.18%6.5M
43.14%7.3M
Deferred tax
-345.99%-61.1M
234.36%165.4M
253.99%48.2M
582.23%168.3M
9.44%-37.4M
12.18%-13.7M
-117.11%-123.1M
-251.94%-31.3M
-730.95%-34.9M
0.48%-41.3M
Other non cash items
-57.58%1.4M
-87.94%14.8M
290.00%3.9M
80.79%-3.9M
-79.82%11.5M
-96.12%3.3M
763.24%122.7M
116.95%1M
-65.04%-20.3M
28,600.00%57M
Change In working capital
87.34%-3M
-570.83%-128.8M
26.41%119.2M
-4,309.09%-185.2M
54.69%-39.1M
25.00%-23.7M
-168.09%-19.2M
275.61%94.3M
-90.43%4.4M
-192.40%-86.3M
-Change in receivables
-120.60%-81.4M
-428.89%-210.5M
1,820.00%38.4M
-925.58%-132.3M
-352.84%-79.7M
-226.55%-36.9M
55.43%-39.8M
109.35%2M
57.57%-12.9M
-519.05%-17.6M
-Change in inventory
352.94%4.3M
19.90%-15.3M
70.69%-3.4M
-272.73%-12.3M
139.62%2.1M
-254.55%-1.7M
-453.70%-19.1M
-1,188.89%-11.6M
-213.79%-3.3M
-431.25%-5.3M
-Change in payables and accrued expense
-376.67%-14.3M
269.12%160.2M
-1.03%76.5M
26.24%55.8M
151.93%30.9M
83.87%-3M
-11.43%43.4M
178.64%77.3M
-64.47%44.2M
-467.28%-59.5M
-Change in other working capital
393.85%88.4M
-1,608.11%-63.2M
-71.05%7.7M
-308.47%-96.4M
294.87%7.6M
739.29%17.9M
-105.86%-3.7M
-60.24%26.6M
53.63%-23.6M
-105.46%-3.9M
Cash from discontinued investing activities
Operating cash flow
125.00%145.8M
31.46%782.7M
60.16%388.4M
43.99%227.5M
57.89%102M
-50.27%64.8M
52.71%595.4M
96.36%242.5M
-25.47%158M
-64.03%64.6M
Investing cash flow
Cash flow from continuing investing activities
-3,664.79%-506.2M
-108.52%-264.4M
22.55%-52.9M
-896.36%-196.7M
-2.84%-29M
125.82%14.2M
72.85%-126.8M
66.15%-68.3M
125.39%24.7M
77.60%-28.2M
Capital expenditure reported
14.95%-9.1M
10.99%-34M
132.88%2.4M
-62.96%-13.2M
-7.76%-12.5M
4.46%-10.7M
-34.98%-38.2M
-35.19%-7.3M
-6.58%-8.1M
-70.59%-11.6M
Net business purchase and sale
--63.2M
----
----
----
----
--0
--0
----
----
----
Net investment purchase and sale
-2,350.20%-560.3M
-160.05%-230.4M
9.34%-55.3M
-659.45%-183.5M
0.60%-16.5M
156.85%24.9M
79.81%-88.6M
68.94%-61M
136.57%32.8M
86.06%-16.6M
Cash from discontinued investing activities
Investing cash flow
-3,664.79%-506.2M
-108.52%-264.4M
22.55%-52.9M
-896.36%-196.7M
-2.84%-29M
125.82%14.2M
72.85%-126.8M
66.15%-68.3M
125.39%24.7M
77.60%-28.2M
Financing cash flow
Cash flow from continuing financing activities
26.97%-86.1M
92.13%-38.3M
112.86%37.3M
72.73%45.6M
98.87%-3.3M
-268.67%-117.9M
-845.33%-486.7M
-919.21%-290M
40.43%26.4M
-10,203.45%-293M
Net issuance payments of debt
----
--0
--0
--0
----
----
---308.8M
--0
--0
----
Net common stock issuance
64.00%-54M
44.10%-167.7M
--0
--0
---17.7M
---150M
---300M
---300M
--0
--0
Proceeds from stock option exercised by employees
-26.48%23.6M
5.98%129.4M
273.00%37.3M
72.73%45.6M
-8.86%14.4M
-54.08%32.1M
86.98%122.1M
-71.75%10M
40.43%26.4M
444.83%15.8M
Net other financing activities
---55.7M
----
----
----
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
26.97%-86.1M
92.13%-38.3M
112.86%37.3M
72.73%45.6M
98.87%-3.3M
-268.67%-117.9M
-845.33%-486.7M
-919.21%-290M
40.43%26.4M
-10,203.45%-293M
Net cash flow
Beginning cash position
199.17%721M
-6.99%241M
-2.49%348.2M
84.16%272M
-50.01%202.1M
-6.99%241M
-4.29%259.1M
18.36%357.1M
-12.19%147.7M
262.28%404.3M
Current changes in cash
-1,047.81%-446.5M
2,751.93%480M
421.93%372.8M
-63.46%76.4M
127.16%69.7M
-126.79%-38.9M
-52.10%-18.1M
-169.93%-115.8M
56.63%209.1M
-553.36%-256.6M
Effect of exchange rate changes
----
--0
--0
-166.67%-200K
----
----
--0
-200.00%-300K
--300K
----
End cash Position
35.82%274.5M
199.17%721M
199.17%721M
-2.49%348.2M
84.16%272M
-50.01%202.1M
-6.99%241M
-6.99%241M
18.36%357.1M
-12.19%147.7M
Free cash flow
152.68%136.7M
34.37%748.7M
66.16%390.8M
42.96%214.3M
68.87%89.5M
-54.58%54.1M
54.09%557.2M
99.15%235.2M
-26.66%149.9M
-69.33%53M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 125.00%145.8M31.46%782.7M60.16%388.4M43.99%227.5M57.89%102M-50.27%64.8M52.71%595.4M96.36%242.5M-25.47%158M-64.03%64.6M
Net income from continuing operations 2,405.06%197.9M40.23%478.6M49.08%153.7M61.40%209.5M65.38%107.5M-81.80%7.9M36.68%341.3M-30.20%103.1M56.20%129.8M-31.94%65M
Operating gains losses ---28.6M------------------------------------
Depreciation and amortization -3.95%7.3M11.07%30.1M5.63%7.5M18.46%7.7M0.00%7.3M22.58%7.6M27.23%27.1M24.56%7.1M18.18%6.5M43.14%7.3M
Deferred tax -345.99%-61.1M234.36%165.4M253.99%48.2M582.23%168.3M9.44%-37.4M12.18%-13.7M-117.11%-123.1M-251.94%-31.3M-730.95%-34.9M0.48%-41.3M
Other non cash items -57.58%1.4M-87.94%14.8M290.00%3.9M80.79%-3.9M-79.82%11.5M-96.12%3.3M763.24%122.7M116.95%1M-65.04%-20.3M28,600.00%57M
Change In working capital 87.34%-3M-570.83%-128.8M26.41%119.2M-4,309.09%-185.2M54.69%-39.1M25.00%-23.7M-168.09%-19.2M275.61%94.3M-90.43%4.4M-192.40%-86.3M
-Change in receivables -120.60%-81.4M-428.89%-210.5M1,820.00%38.4M-925.58%-132.3M-352.84%-79.7M-226.55%-36.9M55.43%-39.8M109.35%2M57.57%-12.9M-519.05%-17.6M
-Change in inventory 352.94%4.3M19.90%-15.3M70.69%-3.4M-272.73%-12.3M139.62%2.1M-254.55%-1.7M-453.70%-19.1M-1,188.89%-11.6M-213.79%-3.3M-431.25%-5.3M
-Change in payables and accrued expense -376.67%-14.3M269.12%160.2M-1.03%76.5M26.24%55.8M151.93%30.9M83.87%-3M-11.43%43.4M178.64%77.3M-64.47%44.2M-467.28%-59.5M
-Change in other working capital 393.85%88.4M-1,608.11%-63.2M-71.05%7.7M-308.47%-96.4M294.87%7.6M739.29%17.9M-105.86%-3.7M-60.24%26.6M53.63%-23.6M-105.46%-3.9M
Cash from discontinued investing activities
Operating cash flow 125.00%145.8M31.46%782.7M60.16%388.4M43.99%227.5M57.89%102M-50.27%64.8M52.71%595.4M96.36%242.5M-25.47%158M-64.03%64.6M
Investing cash flow
Cash flow from continuing investing activities -3,664.79%-506.2M-108.52%-264.4M22.55%-52.9M-896.36%-196.7M-2.84%-29M125.82%14.2M72.85%-126.8M66.15%-68.3M125.39%24.7M77.60%-28.2M
Capital expenditure reported 14.95%-9.1M10.99%-34M132.88%2.4M-62.96%-13.2M-7.76%-12.5M4.46%-10.7M-34.98%-38.2M-35.19%-7.3M-6.58%-8.1M-70.59%-11.6M
Net business purchase and sale --63.2M------------------0--0------------
Net investment purchase and sale -2,350.20%-560.3M-160.05%-230.4M9.34%-55.3M-659.45%-183.5M0.60%-16.5M156.85%24.9M79.81%-88.6M68.94%-61M136.57%32.8M86.06%-16.6M
Cash from discontinued investing activities
Investing cash flow -3,664.79%-506.2M-108.52%-264.4M22.55%-52.9M-896.36%-196.7M-2.84%-29M125.82%14.2M72.85%-126.8M66.15%-68.3M125.39%24.7M77.60%-28.2M
Financing cash flow
Cash flow from continuing financing activities 26.97%-86.1M92.13%-38.3M112.86%37.3M72.73%45.6M98.87%-3.3M-268.67%-117.9M-845.33%-486.7M-919.21%-290M40.43%26.4M-10,203.45%-293M
Net issuance payments of debt ------0--0--0-----------308.8M--0--0----
Net common stock issuance 64.00%-54M44.10%-167.7M--0--0---17.7M---150M---300M---300M--0--0
Proceeds from stock option exercised by employees -26.48%23.6M5.98%129.4M273.00%37.3M72.73%45.6M-8.86%14.4M-54.08%32.1M86.98%122.1M-71.75%10M40.43%26.4M444.83%15.8M
Net other financing activities ---55.7M------------------------------------
Cash from discontinued financing activities
Financing cash flow 26.97%-86.1M92.13%-38.3M112.86%37.3M72.73%45.6M98.87%-3.3M-268.67%-117.9M-845.33%-486.7M-919.21%-290M40.43%26.4M-10,203.45%-293M
Net cash flow
Beginning cash position 199.17%721M-6.99%241M-2.49%348.2M84.16%272M-50.01%202.1M-6.99%241M-4.29%259.1M18.36%357.1M-12.19%147.7M262.28%404.3M
Current changes in cash -1,047.81%-446.5M2,751.93%480M421.93%372.8M-63.46%76.4M127.16%69.7M-126.79%-38.9M-52.10%-18.1M-169.93%-115.8M56.63%209.1M-553.36%-256.6M
Effect of exchange rate changes ------0--0-166.67%-200K----------0-200.00%-300K--300K----
End cash Position 35.82%274.5M199.17%721M199.17%721M-2.49%348.2M84.16%272M-50.01%202.1M-6.99%241M-6.99%241M18.36%357.1M-12.19%147.7M
Free cash flow 152.68%136.7M34.37%748.7M66.16%390.8M42.96%214.3M68.87%89.5M-54.58%54.1M54.09%557.2M99.15%235.2M-26.66%149.9M-69.33%53M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More